Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRP with or without Leukocyte Enrichment for Patellar Tendinopathy
NCT02116946Phase 2Terminated
- Sponsor
- University of British Columbia
- Start
- Mar 2014
- Primary completion
- Dec 2018
- Modality
- Adoptive Cell Transfer
- Countries
- 4
01
Overview
Phase 2, randomised, double-blind trial of autologous platelet-rich plasma in patellar tendinopathy, sponsored by University of British Columbia. Started Mar 2014; status: terminated.
02
Drugs
autologous platelet-rich plasma
03
Conditions
patellar tendinopathy
Beyond the preview
Go deeper on NCT02116946.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02116946.